MeVis Medical Solutions AG (FRA:M3V)

Market Cap	45.14M
Revenue (ttm)	16.64M
Net Income (ttm)	4.30M
Shares Out	n/a
EPS (ttm)	2.36
PE Ratio	10.49
Forward PE	n/a
Dividend	0.95 (3.93%)
Ex-Dividend Date	Mar 26, 2025

Volume	150
Average Volume	38
Open	24.00
Previous Close	24.20
Day's Range	24.00 - 24.20
52-Week Range	22.60 - 26.40
Beta	n/a
RSI	53.45
Earnings Date	Jan 25, 2026

About FRA:M3V

MeVis Medical Solutions AG develops, markets, and sells software for recording, analyzing, and evaluating image data to manufacturers of medical devices, providers of medical IT platforms, and clinical end customers in the United States and Europe. The company provides image-based early detection and diagnosis of epidemiologically important diseases, such as breast, lung, liver, and neurological diseases. It also offers X-ray based radiography procedures, including computed tomography, mammography/digital tomosynthesis, magnetic resonance imagi...

• Industry: Prepackaged Software
• Founded: 1997
• Employees: 100
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: M3V

Financial Performance

In 2024, FRA:M3V's revenue was 16.97 million, a decrease of -2.14% compared to the previous year's 17.34 million. Earnings were 4.56 million, a decrease of -7.29%.